|
Department of Health offices will be closed Monday, May 27th in observance of Memorial Day. Any messages will be returned Tuesday when normal operations resume.
Remember to utilize your Vaccine Management Plan in case of power outage or other emergency and have a safe and happy holiday!
With the 2023-24 school year coming to a close, we would like to remind you of what to do with any remaining vaccine you have in your inventory. Our Facility Closure Policy (page 19 in the Vaccine Management Plan) has all the details on closures. Here are the highlights that apply to closures for the extended summer break:
|
For Closures Greater Than 30 Days:
|
- Notify WAChildhoodVaccines@doh.wa.gov of your facility closure and estimated re-opening date.
- Transfer all vaccine to another enrolled provider who can use the vaccine before expiration.
- Please follow the Vaccine Online Transfer Guide to receive pre-approval and see pages 20-21 in the Vaccine Management Plan for vaccine transfer requirements.
- Adjust inventory in the IIS to reflect the transferred vaccine, if needed.
- Once facility operation resumes, submit DDL temperature data in REDCap for approval to ensure the storage unit is working properly (3-5 days minimum). If unit is working properly, place a new vaccine order.
|
Reminder: As long as all publicly supplied vaccine is transferred out, monthly Temperature Logs are not required to be submitted. Temperature Logs will be required once storage of vaccine received through the Childhood Vaccine Program resumes.
Please feel free to contact WAChildhoodVaccines@doh.wa.gov if you have any questions and we hope you have a well-deserved summer break!
The Washington State Department of Health is hosting a webinar on Thursday, May 30, 2024 from 12-1pm. This webinar will cover school and child care immunization requirements for the upcoming school year and is geared towards healthcare providers. The webinar will be recorded and continuing education credits are available for nurses and medical assistants.
For more information and to register, please visit the training webpage.
Administration of nirsevimab ended March 31st, 2024 and is no longer available to order this season. However, providers may find that they still have doses in their inventory. Remaining nirsevimab is viable until its expiration date. It should continue to be safely stored refrigerated between 36°F to 46°F (2°C to 8°C) and can be used when administration resumes next season. Transfer is not recommended at this time.
More information can be found here: Frequently Asked Questions About RSV Immunization with Monoclonal Antibody for Children 19 Months and Younger | CDC
The Washington State Department of Health (DOH) Health Alert Network (HAN) recently sent an advisory about the rise of pertussis (whooping cough) cases in multiple jurisdictions. As of 5/4/2024, there have been a total of 170 confirmed or probable cases of pertussis across 15 counties. This marks a sixfold increase in reported pertussis cases as compared to this time last year. For more information, please refer to the Weekly Pertussis Update.
Vaccine recommendations:
- All children should receive a series of DTaP at ages 2, 4, and 6 months of age. Boosters should be given at ages 15-18 months and at 4-6 years.
- Adolescents should receive a single dose of Tdap (instead of Td) at the 11-12-year-old visit.
- Adolescents and adults who have not received a dose of Tdap, or whose vaccine status is unknown, should receive a single dose of Tdap.
- Children 7-10 years old who did not complete a series of pertussis-containing vaccine before their seventh birthday should receive a single dose of Tdap. If needed, they should complete their series with Td or Tdap. If a Tdap dose is administered at age 10 or older, the Tdap dose may count as the adolescent Tdap dose.
- All healthcare personnel, regardless of age, should receive a single dose of Tdap if they have not previously received Tdap and regardless of the time since the last dose of Td.
- Pregnant teens and adults should receive Tdap during each pregnancy, preferably between 27 and 36 weeks of gestation.
- Pregnant people who have never received Tdap and who do not receive it during pregnancy should receive it immediately after delivery.
Resources:
Invitations to complete the CVP Provider Satisfaction Survey in REDCap were sent to primary and back-up vaccine coordinators on May 13th. The survey will remain open for 3 weeks. The data we collect helps us to improve customer service and provider support. If you have not already done so, we would love to get your feedback!
|
